Tesla Brings Full SelfDriving Supervised to China After Long Delays as Domestic Rivals Advance
Rail Vikas Nigam Q4 FY26 Results Net Profit Drops 59 YoY Despite Revenue Growth
Meta Shares Slide After Quarterly Report Iran Internet Disruptions Weigh on User Metrics
Tech IPOs Take a Backseat as Biotech and Healthcare Dominate US Public Listings
Nvidias Record Earnings Fail to Impress PostMarket Dip Reflects Investor Skepticism on Growth Pace
Foresight Ventures Leads 30 Million Investment in PopDEX for TraderCentric Perpetual DEX Development
American Strategic Investment Co Q1 2026 Earnings Widened Loss Amidst Portfolio Realignment
NOC Q1 2026 Earnings Slight EPS Beat Amid Quiet Revenue Disclosure
OPKO Health Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains 154
Saia Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly
BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS
WMB Q1 2026 Earnings EPS Miss Weighs on Stock Natural Gas Infrastructure Firm Faces Profitability Headwinds
Golden Entertainment GDEN Holds Steady at 2855 Key Levels in Focus
Valmont Industries VMI Tests Resistance Near 539 After 145 Gain
Clough Global Dividend and Income Fund GLV Edges Higher as Price Tests Key Resistance
Cummins CMI Posts Modest Gain as Stock Consolidates Below Resistance
Palladyne AI Corp Warrants PDYNW Edge Lower Amid Thin Trading
Trump Seeks Supreme Court Intervention to Delay TikTok Ban Market Watches Regulatory Crossroads
DAKT Q1 2026 Earnings EPS Misses Estimates as Stock Gains 284
SolarEdge Technologies SEDG Slides 17 Amid Broader Solar Headwinds Key Support Levels Tested
Bloom Energy Secures 26B Deal Signaling Potential Growth
UK Exports to US Plunge 25 Following Trumps Liberation Day Tariff Measures
South East Water Faces Operational Strain as Demand Surges Amid Record Heat
Rising Homeowners Insurance Costs Strategies for Policyholders to Explore
Wyndham Clarks 2026 CJ Cup Byron Nelson Win Signals Career Resurgence
Asian Stocks Poised for Gains Amid Iran Deal Optimism
Wall Street Analysts Weigh In on ResMed Bullish Sentiment or Caution Ahead